氢化可的松17-丁酸酯; 17-丁酸皮质醇酯; 氢化可的松17丁酸杂质; 17-丁酸11β,17,21-三羟基孕-4-烯-3,20-二酮; 氢化可的松丁酸酯; 氢化可的松丁酸酯; 尤卓尔
LOCOID LIPOCREAM; 11b,17,21-Trihydroxypregn-4-ene-3,20-dione 17-Butyrate; Pregn-4-ene-3,20-dione, 11,21-dihydroxy-17-(1-oxobutoxy)-, (11β)-; butanoate de (8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(hydroxyacétyl)-10,13-diméthyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tétradécahydro-1H-cyclopenta[a]phénanthrén-17-yle; Hydrocortisone Butyrate; Hydrocortisone butyrate (JP15/USP); (8S,9S,10R,11S,13S,14S,17R)-11-Hydroxy-17-(hydroxyacetyl)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-ylbutanoat; Hydrocortisone 17-butyrate; (11β)-11,21-Dihydroxy-17-(1-oxobutoxy)pregn-4-ene-3,20-dione; cortisol 17-butyrate; MFCD00083364; EINECS 237-093-4; 11β,17,21-Trihydroxypregn-4-ene-3,20-dione 17-Butyrate; (11β)-11,21-Dihydroxy-3,20-dioxopregn-4-en-17-yl butyrate; Butanoic acid, (11β)-11,21-dihydroxy-3,20-dioxopregn-4-en-17-yl ester; (8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(hydroxyacetyl)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl butanoate; locoid; (11β)-11,21-dihydroxy-3,20-dioxopregn-4-en-17-yl butanoate; Hydrocortisone butyrate [USAN:BAN:JAN]; Pregn-4-ene-3,20-dione, 11,21-dihydroxy-17-(1-oxobutoxy)-, (11-β)-; [(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate; (11beta)-11,21-dihydroxy-3,20-dioxopregn-4-en-17-yl butanoate; (9xi,11beta,14xi)-11,21-dihydroxy-3,20-dioxopregn-4-en-17-yl butanoate; Hydrocortisone-17-butyrate
室温
1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:2 3.氢键受体数量:6 4.可旋转化学键数量:6 5.互变异构体数量:15 6.拓扑分子极性表面积:101 7.重原子数量:31 8.表面电荷:0 9.复杂度:817 10.同位素原子数量:0 11.确定原子立构中心数量:7 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1